Episodic migraine
Acute · Established useTGA-approved acute migraine treatment in adults with or without aura. An acute use label is not a chronic-prevention claim.
TGA: Nurtec ODT approved indicationsRimegepant
Rimegepant is one option discussed in migraine care. Clea explains where it sits in the treatment landscape without recommending it for an individual person.
Checking review recordSource references are available below.
ROLE BY HEADACHE TYPE
Which patterns is this used for?
Frequency and symptoms can overlap: someone can have chronic migraine and vestibular symptoms, for example. Choose a label to explore usual roles, not to select a treatment for yourself.
General information, not personal medical advice. Some uses are off-label or supported by limited evidence. TGA approval, PBS eligibility and individual suitability differ. Do not start, stop or change treatment without your clinician or pharmacist.
Chronic migraine
Acute · Established useTGA-approved acute migraine treatment in adults with or without aura. An acute use label is not a chronic-prevention claim.
TGA: Nurtec ODT approved indicationsMigraine with aura
Acute · Established useTGA-approved acute migraine treatment in adults with or without aura. An acute use label is not a chronic-prevention claim.
TGA: Nurtec ODT approved indicationsMigraine without aura
Acute · Established useTGA-approved acute migraine treatment in adults with or without aura. An acute use label is not a chronic-prevention claim.
TGA: Nurtec ODT approved indicationsMenstrual-related migraine
Acute · Established useTGA-approved acute migraine treatment in adults with or without aura. An acute use label is not a chronic-prevention claim.
TGA: Nurtec ODT approved indicationsEpisodic migraine
Prevention · Established useThe Australian preventive indication is episodic migraine in eligible adults. It must not be relabelled as approved chronic-migraine prevention.
TGA: Nurtec ODT approved indicationsVestibular migraine
Prevention · Emerging evidenceA small 33-person prospective cohort reported improvement over four weeks, but had no placebo control. This is preliminary vestibular evidence, distinct from the established episodic-migraine preventive indication.
Rimegepant vestibular migraine prospective cohort (2025)Vestibular migraine
Acute · Emerging evidenceAn observational 2026 cohort studied acute vestibular vertigo. This does not provide the certainty of a randomised controlled trial or establish an Australian vestibular-specific indication.
Rimegepant for acute vestibular vertigo: observational cohort (2026)Use labels are an editorial guide to the cited sources, not a clinical recommendation or an independent clinical-review badge. Each profile retains its separate review status.
Where it fits
Migraine-specific acute treatment and, under approved conditions, prevention.
Administration
Oral dissolving tablet.
What we know
Randomised trials support its approved migraine uses.
Access
TGA-approved uses and current PBS/private access should be checked at time of prescribing.
Mechanism, in plain language.
Gepants block the CGRP receptor. CGRP is an important signalling molecule in migraine biology, but blocking it does not mean every person will respond or that CGRP explains every feature of migraine.
Decide what “working” would mean.
First establish whether the clinician prescribed rimegepant for an attack or for prevention. Acute response and changes in monthly migraine burden are different measures. Do not judge a chronic preventive effect from an acute-treatment rating.
Questions for the treatment conversation
- What is the goal of using Rimegepant in my migraine plan?
- How will we decide whether it is helping enough to continue?
- What side effects or warning signs should I know about?
- Do any of my other medicines, conditions, pregnancy plans or allergies change the discussion?
- What is the current Australian access pathway and likely cost for me?
Give the next review better evidence.
Before and after a treatment change, record migraine-like days, total headache days, acute medicine days, severity and functional impact. If you notice side effects, record what happened and when rather than relying on memory at the next appointment.
Add to My TreatmentsSAFETY
Suitability is individual.
Interactions, liver/renal factors and individual medical history require prescriber review.
Clea does not recommend, start, stop or change medicines. Discuss individual treatment decisions with your GP, neurologist, pharmacist or other treating clinician.
DRUGS.COM · EXTERNAL PATIENT REVIEWS
Read the right review category.
Original Drugs.com ratings use a 10-point scale. Read the source condition label and review count before drawing conclusions. “Migraine Prevention” is not a vestibular-only or episodic-only score, and a review category does not establish an approved indication.
Chronic MigraineExact source category · Opens Drugs.com ↗Migraine PreventionBroader source / search, not subtype-specific · Opens Drugs.com ↗
Source links only. Clea has not imported ratings or review text. Republishing source scores requires permission; no licensed ratings feed is connected. Drugs.com is US-focused, so medicine names and approved uses may differ from Australia. Reviews are self-selected experiences, not comparative evidence of effectiveness.
CLEA COMMUNITY EXPERIENCE · NOT DRUGS.COM
Compare experiences from the same pattern.
People can report a migraine frequency and a symptom pattern separately, such as chronic plus vestibular. Labels are self-reported, not independently diagnosed or verified. Groups can overlap and cannot establish that one treatment works better than another.
Viewing: All migraine frequencies · All symptom patterns
Loading this group…
Small, self-selected groups are not clinical trials. Scores are perceived experiences and may reflect dose, treatment duration, other conditions and access as well as benefit. No personal identities are published here.
Log in to add your experienceCheck the original source.
Therapeutic Goods AdministrationPharmaceutical Benefits SchemeMigraine & Headache Australia drug directoryKeep your treatment story in one place.
Add treatments you have tried to My Clea, then use your history when preparing for your next appointment.
Open My Clea